Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1186/1479-5876-11-78

http://scihub22266oqcxt.onion/10.1186/1479-5876-11-78
suck pdf from google scholar
23531302!3636128!23531302
unlimited free pdf from europmc23531302    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid23531302      J+Transl+Med 2013 ; 11 (?): 78
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice #MMPMID23531302
  • Nasir GA; Mohsin S; Khan M; Shams S; Ali G; Khan SN; Riazuddin S
  • J Transl Med 2013[Mar]; 11 (?): 78 PMID23531302show ga
  • BACKGROUND: Mesenchymal stem cell (MSC) transplantation has emerged as a promising therapy for liver fibrosis. Issues concerning poor MSC survival and engraftment in the fibrotic liver still persist and warrant development of a strategy to increase MSC potency for liver repair. The present study was designed to examine a synergistic role for Interleukin-6 (IL-6) and MSCs therapy in the recovery of carbon tetrachloride (CCl(4)) induced injured hepatocytes in vitro and in vivo. METHODS: Injury was induced through 3 mM and 5 mM CCl(4) treatment of cultured hepatocytes while fibrotic mouse model was established by injecting 0.5 ml/kg CCl(4) followed by treatment with IL-6 and MSCs. Effect of MSCs and IL-6 treatment on injured hepatocytes was determined by lactate dehydrogenase release, RT-PCR for (Bax, Bcl-xl, Caspase3, Cytokeratin 8, NFkappaB, TNF-alpha) and annexin V apoptotic detection. Analysis of MSC and IL-6 treatment on liver fibrosis was measured by histopathology, PAS, TUNEL and Sirius red staining, RT-PCR, and liver function tests for Bilirubin and Alkaline Phosphatase (ALP). RESULTS: A significant reduction in LDH release and apoptosis was observed in hepatocytes treated with a combination of MSCs and IL-6 concomitant with upregulation of anti-apoptotic gene Bcl-xl expression and down regulation of bax, caspase3, NFkappaB and TNF-alpha. Adoptive transfer of MSCs in fibrotic liver pretreated with IL-6 resulted increased MSCs homing and reduced fibrosis and apoptosis. Hepatic functional assessment demonstrated reduced serum levels of Bilirubin and ALP. CONCLUSION: Pretreatment of fibrotic liver with IL-6 improves hepatic microenvironment and primes it for MSC transplantation leading to enhanced reduction of liver injury after fibrosis. Synergistic effect of IL-6 and MSCs seems a favored therapeutic option in attenuation of liver apoptosis and fibrosis accompanied by improved liver function.
  • |*Gene Expression Regulation[MESH]
  • |*Mesenchymal Stem Cell Transplantation[MESH]
  • |Animals[MESH]
  • |Apoptosis[MESH]
  • |Carbon Tetrachloride/pharmacology[MESH]
  • |Coculture Techniques[MESH]
  • |Female[MESH]
  • |Glycogen/metabolism[MESH]
  • |Hepatocytes/cytology/drug effects[MESH]
  • |Inflammation[MESH]
  • |Interleukin-6/*metabolism[MESH]
  • |Liver Cirrhosis/*metabolism/*therapy[MESH]
  • |Mesenchymal Stem Cells/*cytology[MESH]
  • |Mice[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box